{"id":353863,"date":"2025-08-28T09:40:50","date_gmt":"2025-08-28T09:40:50","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-par-drugs-and-chemicals-limited\/"},"modified":"2025-09-13T07:30:15","modified_gmt":"2025-09-13T07:30:15","slug":"how-to-buy-par-drugs-and-chemicals-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","title":{"rendered":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-353863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Par Drugs and Chemicals Limited (PAR) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m s\u00fcrecini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Par Drugs and Chemicals Limited (PAR) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m s\u00fcrecini \u00f6\u011frenin."},"intro":"Hindistan'\u0131n ila\u00e7 sekt\u00f6r\u00fcne yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Par Drugs and Chemicals Limited, h\u0131zla b\u00fcy\u00fcyen API \u00fcretim alan\u0131nda benzersiz bir f\u0131rsat sunuyor. Hindistan k\u00fcresel bir ila\u00e7 devi olarak ortaya \u00e7\u0131karken, bu \u015firket d\u00fcnyan\u0131n en h\u0131zl\u0131 b\u00fcy\u00fcyen sa\u011fl\u0131k pazarlar\u0131ndan birindeki b\u00fcy\u00fcmeyi yakalaman\u0131z i\u00e7in kap\u0131n\u0131z olabilir. PAR'\u0131 portf\u00f6y\u00fcn\u00fcze nas\u0131l ekleyebilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Hindistan'\u0131n ila\u00e7 sekt\u00f6r\u00fcne yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Par Drugs and Chemicals Limited, h\u0131zla b\u00fcy\u00fcyen API \u00fcretim alan\u0131nda benzersiz bir f\u0131rsat sunuyor. Hindistan k\u00fcresel bir ila\u00e7 devi olarak ortaya \u00e7\u0131karken, bu \u015firket d\u00fcnyan\u0131n en h\u0131zl\u0131 b\u00fcy\u00fcyen sa\u011fl\u0131k pazarlar\u0131ndan birindeki b\u00fcy\u00fcmeyi yakalaman\u0131z i\u00e7in kap\u0131n\u0131z olabilir. PAR'\u0131 portf\u00f6y\u00fcn\u00fcze nas\u0131l ekleyebilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Par Drugs and Chemicals Limited Hisse Senedi Performans\u0131n\u0131 Anlamak<\/h2> <h3>G\u00fcncel Hisse Fiyat\u0131 Analizi<\/h3> <p>13 Eyl\u00fcl 2025 itibar\u0131yla, Par Drugs and Chemicals Limited (NSE: PAR) hisse ba\u015f\u0131na <strong>Rs. 108.64<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131, 52 haftal\u0131k en y\u00fcksek fiyat\u0131 Rs. 348.45 ve 52 haftal\u0131k en d\u00fc\u015f\u00fck fiyat\u0131 Rs. 81.01 oldu (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct<\/a>). Bu, y\u0131ll\u0131k zirvelerden %54,22'lik dramatik bir d\u00fc\u015f\u00fc\u015f\u00fc temsil ediyor ve de\u011fer yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in potansiyel f\u0131rsatlar yarat\u0131yor.<\/p> <h3>\u00d6nemli Tarih Uyar\u0131s\u0131: Kas\u0131m 2025 Kazan\u00e7 Etkisi<\/h3> <p>Kas\u0131m 2025 ba\u015f\u0131nda Par Drugs'\u0131n bir sonraki \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131n\u0131 takviminize not edin. Tarihsel veriler, bu t\u00fcr olaylar\u0131n genellikle \u00f6nemli fiyat hareketlerine neden oldu\u011funu g\u00f6steriyor. \u015eirketin son kazanc\u0131 7 A\u011fustos 2025'te a\u00e7\u0131kland\u0131 ve sat\u0131\u015flar y\u0131ll\u0131k bazda %2,14 azalarak Rs. 22,33 crore oldu (<a href=\"https:\/\/blinkx.in\/insights\/history\/par-drugs-chemicals-ltd-share-price-history\">BlinkX Tarihsel Veriler<\/a>).<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi:<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat De\u011fi\u015fimi<\/th><th>Sonu\u00e7<\/th><\/tr> <\/thead> <tbody> <tr><td>A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>-%4,35 (g\u00fcn)<\/td><td>Sat\u0131\u015flarda d\u00fc\u015f\u00fc\u015f<\/td><\/tr> <tr><td>Mar 2025<\/td><td>4. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>+%15,22 (ay)<\/td><td>G\u00fc\u00e7l\u00fc toparlanma<\/td><\/tr> <tr><td>Eyl 2024<\/td><td>\u00d6nceki \u00c7eyrek<\/td><td>Y\u0131ll\u0131k %33,88 art\u0131\u015f<\/td><td>M\u00fckemmel b\u00fcy\u00fcme<\/td><\/tr> <\/tbody> <\/table> <p>Bu model, kazan\u00e7 raporlar\u0131n\u0131n \u00f6zellikle piyasan\u0131n ge\u00e7ici aksakl\u0131klara a\u015f\u0131r\u0131 tepki verdi\u011fi durumlarda m\u00fckemmel giri\u015f noktalar\u0131 yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>Par Drugs hisseleri, sekt\u00f6r zorluklar\u0131na ra\u011fmen ola\u011fan\u00fcst\u00fc diren\u00e7 g\u00f6stererek <strong>son alt\u0131 ayda %7,34 kazan\u00e7 sa\u011flad\u0131<\/strong> (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct Performans Verileri<\/a>). \u0130\u015fte ayl\u0131k da\u011f\u0131l\u0131m:<\/p> <ul> <li><strong>Mart 2025<\/strong>: Rs. 115-125 aral\u0131\u011f\u0131 - Y\u0131la g\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7<\/li> <li><strong>Nisan 2025<\/strong>: D\u00fczeltme d\u00f6nemi - Sekt\u00f6r genelinde endi\u015feler<\/li> <li><strong>May\u0131s 2025<\/strong>: Rs. 95-105 aral\u0131\u011f\u0131 - Destek seviyeleri aran\u0131yor<\/li> <li><strong>Haziran 2025<\/strong>: Rs. 85-95 aral\u0131\u011f\u0131 - Y\u0131ll\u0131k dipler test ediliyor<\/li> <li><strong>Temmuz 2025<\/strong>: Rs. 90-100 aral\u0131\u011f\u0131 - \u0130lk toparlanma i\u015faretleri<\/li> <li><strong>A\u011fustos 2025<\/strong>: Rs. 100-110 aral\u0131\u011f\u0131 - \u0130stikrarl\u0131 yukar\u0131 y\u00f6nl\u00fc momentum<\/li> <li><strong>Eyl\u00fcl 2025<\/strong>: Rs. 105-115 aral\u0131\u011f\u0131 - G\u00fcncel i\u015flem aral\u0131\u011f\u0131<\/li> <\/ul> <p>Hisse senedi, Haziran 2025'te a\u015f\u0131r\u0131 sat\u0131m ko\u015fullar\u0131na ula\u015ft\u0131ktan sonra klasik toparlanma modelleri sergiliyor. Rs. 81,01 dip seviyesinden son s\u0131\u00e7rama, bu seviyelerde g\u00fc\u00e7l\u00fc kurumsal destek oldu\u011funu g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut temel veriler ve sekt\u00f6r b\u00fcy\u00fcme projeksiyonlar\u0131na dayanarak, i\u015fte ger\u00e7ek\u00e7i fiyat tahminimiz:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: Rs. 125-140 \u2192 <strong>AL<\/strong> tavsiyesi<br>K\u00fcresel API talebinin artmas\u0131yla g\u00fc\u00e7l\u00fc toparlanma bekleniyor<\/li> <li><strong>2026 Tahmini<\/strong>: Rs. 150-170<br>Hindistan'\u0131n API \u00fcretim geni\u015flemesinden faydalanma<\/li> <li><strong>2028 Projeksiyonu<\/strong>: Rs. 250-300<br>Pazar liderli\u011fi konsolidasyonu ve ihracat b\u00fcy\u00fcmesi<\/li> <li><strong>2030 Hedefi<\/strong>: Rs. 400-500<br>K\u00fcresel ila\u00e7 tedarik zinciri hakimiyeti<\/li> <\/ul> <p>Bu projeksiyonlar, Hindistan'\u0131n API end\u00fcstrisinin %13,7 CAGR b\u00fcy\u00fcme oran\u0131 ve \u015firketin bor\u00e7suz bilan\u00e7o durumu ile uyumludur (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">OMR Global End\u00fcstri Raporu<\/a>).<\/p> <h2>\u26a0\ufe0f PAR Yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Risk De\u011ferlendirmesi<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Ana Riskler:<\/h3> <ul> <li><strong>Y\u00fcksek Volatilite<\/strong>: 52 haftal\u0131k aral\u0131k a\u015f\u0131r\u0131 fiyat dalgalanmalar\u0131n\u0131 g\u00f6steriyor (Rs. 81-348)<\/li> <li><strong>Reg\u00fclasyon Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: \u0130la\u00e7 sekt\u00f6r\u00fc s\u00fcrekli d\u00fczenleyici de\u011fi\u015fikliklerle kar\u015f\u0131 kar\u015f\u0131ya<\/li> <li><strong>\u0130hracat Hassasiyeti<\/strong>: Gelirin %40'\u0131 ihracattan, d\u00f6viz dalgalanmalar\u0131na kar\u015f\u0131 hassas<\/li> <li><strong>Rekabet Bask\u0131s\u0131<\/strong>: Daha b\u00fcy\u00fck oyuncular API \u00fcretim alan\u0131nda hakim<\/li> <li><strong>Hammadde Maliyetleri<\/strong>: Kimyasal girdi fiyatlar\u0131ndaki dalgalanmalar marjlar\u0131 etkiliyor<\/li> <\/ul> <h3>2025 i\u00e7in Olumlu Sinyaller:<\/h3> <ul> <li><strong>Bor\u00e7suz \u015eirket<\/strong>: S\u0131f\u0131r bor\u00e7 finansal esneklik sa\u011fl\u0131yor (<a href=\"https:\/\/simplywall.st\/stocks\/in\/pharmaceuticals-biotech\/nse-par\/par-drugs-and-chemicals-shares\">Simply Wall St Analizi<\/a>)<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Hindistan k\u00fcresel API merkezi haline geliyor ve %8 pazar pay\u0131na sahip<\/li> <li><strong>Maliyet Avantajlar\u0131<\/strong>: Bat\u0131l\u0131 rakiplere g\u00f6re %40 daha d\u00fc\u015f\u00fck \u00fcretim maliyetleri<\/li> <li><strong>Jeopolitik Faydalar<\/strong>: \u00c7in ticaret gerilimleri Hindistanl\u0131 \u00fcreticilere avantaj sa\u011fl\u0131yor<\/li> <li><strong>G\u00fc\u00e7l\u00fc Marjlar<\/strong>: %59,80 br\u00fct marj fiyatlama g\u00fcc\u00fcn\u00fc g\u00f6steriyor<\/li> <\/ul> <h2>\ud83d\udcf0 \u00d6nemli Haber Analizi (Son 6 Ay)<\/h2> <h3>Mali Performans G\u00fcncellemeleri:<\/h3> <p>\u015eirket, 2026 1. \u00e7eyrek sonu\u00e7lar\u0131nda hisse ba\u015f\u0131na Rs. 2,70 EPS bildirerek y\u0131ll\u0131k Rs. 2,06'ya k\u0131yasla %31 sa\u011fl\u0131kl\u0131 art\u0131\u015f g\u00f6sterdi (<a href=\"https:\/\/www.valueresearchonline.com\/stocks\/251559\/par-drugs-and-chemicals-ltd\/\">Value Research Online<\/a>). Ancak, Mart 2025 \u00e7eyrek sat\u0131\u015flar\u0131 %2,14 azalarak Rs. 22,33 crore oldu ve baz\u0131 operasyonel zorluklar\u0131 ortaya koydu.<\/p> <h3>Operasyonel Verimlilik \u0130yile\u015ftirmeleri:<\/h3> <p>\u00d6zellikle, \u015firket Mart 2025 itibar\u0131yla nakit d\u00f6n\u00fc\u015f\u00fcm d\u00f6ng\u00fcs\u00fcn\u00fc sadece 15 g\u00fcne d\u00fc\u015f\u00fcrerek m\u00fckemmel i\u015fletme sermayesi y\u00f6netimi sergiledi (<a href=\"https:\/\/www.screener.in\/company\/PAR\/\">Screener.in Finansallar<\/a>). Bu verimlilik art\u0131\u015f\u0131, sermaye yo\u011fun ila\u00e7 sekt\u00f6r\u00fcnde rekabet avantaj\u0131 sa\u011fl\u0131yor.<\/p> <h3>Kurumsal Y\u00f6netim:<\/h3> <p>27 Eyl\u00fcl 2025'te planlanan 26. Ola\u011fan Genel Kurul, istikrarl\u0131 y\u00f6netim ve rutin kurumsal faaliyetleri g\u00f6steriyor, b\u00fcy\u00fck aksakl\u0131klar yok (<a href=\"https:\/\/www.tickertape.in\/stocks\/par-drugs-and-chemicals-PARR\">Tickertape Kurumsal \u0130\u015flemler<\/a>).<\/p> <h2>\ud83c\udfaf Yeni Ba\u015flayanlar i\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2> <h3>Ciddi Tavsiyeler:<\/h3> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Niyet etti\u011finiz pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fcn %10-20'si ile ba\u015flayarak suyu test edin<\/li> <li><strong>D\u00fc\u015f\u00fc\u015fleri Bekleyin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 Rs. 100 alt\u0131 daha iyi giri\u015f noktalar\u0131 sa\u011flayabilir<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Zamanlama riskini azaltmak i\u00e7in al\u0131mlar\u0131 3-6 ay aras\u0131nda yay\u0131n\u0131z<\/li> <\/ol> <h3>Esprili Tecr\u00fcbeli Tavsiyesi:<\/h3> <p>\"PAR hissesi ticareti, ila\u00e7 \u00fcretimi gibidir - bazen karl\u0131 form\u00fcl\u00fc g\u00f6rmek i\u00e7in kar\u0131\u015f\u0131m s\u00fcrecine katlanman\u0131z gerekir. Volatilite s\u0131ras\u0131nda panik yapmay\u0131n; bu kimyasallar\u0131n do\u011fru tepki vermesi zaman al\u0131r!\"<\/p> <h2>\u2705 Ad\u0131m Ad\u0131m: Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Uluslararas\u0131 Arac\u0131 Kurum Se\u00e7in<\/td><td>NSE\/BSE i\u015flem eri\u015fimini desteklemeli<\/td><\/tr> <tr><td>2<\/td><td>KYC Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Hint piyasas\u0131na eri\u015fim i\u00e7in PAN kart gereklidir<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>\u0130lk pozisyon i\u00e7in minimum 50$ \u00f6nerilir<\/td><\/tr> <tr><td>4<\/td><td>\"PAR\" Ticker'\u0131n\u0131 Aray\u0131n<\/td><td>Ulusal Borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Limit Emri Verin<\/td><td>Dalgal\u0131 d\u00f6nemlerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu \u0130zleyin<\/td><td>\u0130la\u00e7 hisseleri aktif y\u00f6netim gerektirir<\/td><\/tr> <tr><td>7<\/td><td>Stop-Loss Belirleyin<\/td><td>A\u015f\u0131r\u0131 volatiliteye kar\u015f\u0131 koruma sa\u011flar<\/td><\/tr> <tr><td>8<\/td><td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td><td>Kazan\u00e7 raporlar\u0131 b\u00fcy\u00fck fiyat hareketlerini tetikler<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden \u00dcst\u00fcn<\/h2> <p>Pocket Option, PAR yat\u0131r\u0131m\u0131 i\u00e7in m\u00fckemmel \u00f6zelliklerle hisse senedi ticaret eri\u015filebilirli\u011fini devrim niteli\u011finde art\u0131r\u0131yor:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma Avantaj\u0131<\/strong>: Sadece 5$ ile ticarete ba\u015flayarak Par Drugs hisseleriyle stratejileri b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan test etmek i\u00e7in ideal (<a href=\"https:\/\/pocketoption.com\/blog\/en\/interesting\/trading-platforms\/what-is-the-minimum-deposit-in-pocket-option\/\">Pocket Option Para Yat\u0131rma Rehberi<\/a>).<\/li> <li><strong>\u015eim\u015fek H\u0131z\u0131nda Do\u011frulama<\/strong>: Tek bir kimlik belgesi ile dakikalar i\u00e7inde KYC tamamlayarak f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda piyasaya haz\u0131r olun.<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla para \u00e7ekme y\u00f6ntemi ile ba\u015far\u0131l\u0131 PAR i\u015flemlerinden kazan\u00e7lar\u0131n\u0131z\u0131 kolayca eri\u015febilirsiniz.<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve profesyonel grafik ara\u00e7lar\u0131, Par Drugs'\u0131n teknik desenlerini yeni ba\u015flayanlar i\u00e7in bile analiz etmeyi kolayla\u015ft\u0131r\u0131r.<\/p> <h2>\ud83c\udfed \u015eirket Genel Bak\u0131\u015f\u0131: Par Drugs 2025<\/h2> <p>Par Drugs and Chemicals Limited, 1999'dan beri faaliyet g\u00f6steren ve Gujarat'\u0131n Bhavnagar ve Ankleshwar b\u00f6lgelerinde \u00fcretim tesisleri bulunan Hindistan'\u0131n ila\u00e7 bile\u015fenleri sekt\u00f6r\u00fcnde k\u00f6kl\u00fc bir oyuncudur. \u015eirket, hem yerel hem de uluslararas\u0131 pazarlara hizmet veren 15 aktif farmas\u00f6tik bile\u015fen (API) ve 10 ince kimyasal \u00fcretiminde uzmanla\u015fm\u0131\u015ft\u0131r (<a href=\"https:\/\/www.moneycontrol.com\/india\/stockpricequote\/chemicals\/pardrugschemicals\/PDC02\">Moneycontrol \u015eirket Profili<\/a>).<\/p> <h3>G\u00fcncel Pazar Konumu:<\/h3> <ul> <li>Piyasa De\u011feri: Rs. 133,68 crore<\/li> <li>F\/K Oran\u0131: 9,87 (sekt\u00f6re g\u00f6re d\u00fc\u015f\u00fck de\u011ferli)<\/li> <li>F\/\u00d6 Oran\u0131: 1,41 (makul de\u011ferleme)<\/li> <li>Bor\u00e7: S\u0131f\u0131r bor\u00e7 - finansal olarak istikrarl\u0131<\/li> <\/ul> <h3>\u00dcr\u00fcn Portf\u00f6y\u00fc \u015eunlar\u0131 \u0130\u00e7erir:<\/h3> <ul> <li>Magnezyum hidroksit ve oksit \u00fcr\u00fcnleri<\/li> <li>Sucralfate ve almagate BP<\/li> <li>\u00c7e\u015fitli magnezyum bile\u015fikleri<\/li> <li>Farmas\u00f6tik s\u0131n\u0131f kimyasallar<\/li> <\/ul> <h3>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/h3> <p>Par Drugs, Hindistan'\u0131n D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc'n\u00fcn \u00f6n yeterlilik listesine %57 API tedarik etti\u011fi bir sekt\u00f6rde faaliyet g\u00f6stermektedir; bu da PAR gibi \u015firketleri k\u00fcresel sa\u011fl\u0131k tedarik zincirlerinde kritik oyuncular haline getirmektedir (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">K\u00fcresel API Pazar Raporu<\/a>). Bu durum, g\u00fcvenilir farmas\u00f6tik bile\u015fenlere artan k\u00fcresel talep i\u00e7in onlar\u0131 m\u00fckemmel bir konuma getiriyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Par Drugs and Chemicals Limited Hisse Senedi Performans\u0131n\u0131 Anlamak<\/h2>\n<h3>G\u00fcncel Hisse Fiyat\u0131 Analizi<\/h3>\n<p>13 Eyl\u00fcl 2025 itibar\u0131yla, Par Drugs and Chemicals Limited (NSE: PAR) hisse ba\u015f\u0131na <strong>Rs. 108.64<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131, 52 haftal\u0131k en y\u00fcksek fiyat\u0131 Rs. 348.45 ve 52 haftal\u0131k en d\u00fc\u015f\u00fck fiyat\u0131 Rs. 81.01 oldu (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct<\/a>). Bu, y\u0131ll\u0131k zirvelerden %54,22&#8217;lik dramatik bir d\u00fc\u015f\u00fc\u015f\u00fc temsil ediyor ve de\u011fer yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in potansiyel f\u0131rsatlar yarat\u0131yor.<\/p>\n<h3>\u00d6nemli Tarih Uyar\u0131s\u0131: Kas\u0131m 2025 Kazan\u00e7 Etkisi<\/h3>\n<p>Kas\u0131m 2025 ba\u015f\u0131nda Par Drugs&#8217;\u0131n bir sonraki \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131n\u0131 takviminize not edin. Tarihsel veriler, bu t\u00fcr olaylar\u0131n genellikle \u00f6nemli fiyat hareketlerine neden oldu\u011funu g\u00f6steriyor. \u015eirketin son kazanc\u0131 7 A\u011fustos 2025&#8217;te a\u00e7\u0131kland\u0131 ve sat\u0131\u015flar y\u0131ll\u0131k bazda %2,14 azalarak Rs. 22,33 crore oldu (<a href=\"https:\/\/blinkx.in\/insights\/history\/par-drugs-chemicals-ltd-share-price-history\">BlinkX Tarihsel Veriler<\/a>).<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi:<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat De\u011fi\u015fimi<\/th>\n<th>Sonu\u00e7<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>-%4,35 (g\u00fcn)<\/td>\n<td>Sat\u0131\u015flarda d\u00fc\u015f\u00fc\u015f<\/td>\n<\/tr>\n<tr>\n<td>Mar 2025<\/td>\n<td>4. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>+%15,22 (ay)<\/td>\n<td>G\u00fc\u00e7l\u00fc toparlanma<\/td>\n<\/tr>\n<tr>\n<td>Eyl 2024<\/td>\n<td>\u00d6nceki \u00c7eyrek<\/td>\n<td>Y\u0131ll\u0131k %33,88 art\u0131\u015f<\/td>\n<td>M\u00fckemmel b\u00fcy\u00fcme<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Bu model, kazan\u00e7 raporlar\u0131n\u0131n \u00f6zellikle piyasan\u0131n ge\u00e7ici aksakl\u0131klara a\u015f\u0131r\u0131 tepki verdi\u011fi durumlarda m\u00fckemmel giri\u015f noktalar\u0131 yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>Par Drugs hisseleri, sekt\u00f6r zorluklar\u0131na ra\u011fmen ola\u011fan\u00fcst\u00fc diren\u00e7 g\u00f6stererek <strong>son alt\u0131 ayda %7,34 kazan\u00e7 sa\u011flad\u0131<\/strong> (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct Performans Verileri<\/a>). \u0130\u015fte ayl\u0131k da\u011f\u0131l\u0131m:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: Rs. 115-125 aral\u0131\u011f\u0131 &#8211; Y\u0131la g\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7<\/li>\n<li><strong>Nisan 2025<\/strong>: D\u00fczeltme d\u00f6nemi &#8211; Sekt\u00f6r genelinde endi\u015feler<\/li>\n<li><strong>May\u0131s 2025<\/strong>: Rs. 95-105 aral\u0131\u011f\u0131 &#8211; Destek seviyeleri aran\u0131yor<\/li>\n<li><strong>Haziran 2025<\/strong>: Rs. 85-95 aral\u0131\u011f\u0131 &#8211; Y\u0131ll\u0131k dipler test ediliyor<\/li>\n<li><strong>Temmuz 2025<\/strong>: Rs. 90-100 aral\u0131\u011f\u0131 &#8211; \u0130lk toparlanma i\u015faretleri<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: Rs. 100-110 aral\u0131\u011f\u0131 &#8211; \u0130stikrarl\u0131 yukar\u0131 y\u00f6nl\u00fc momentum<\/li>\n<li><strong>Eyl\u00fcl 2025<\/strong>: Rs. 105-115 aral\u0131\u011f\u0131 &#8211; G\u00fcncel i\u015flem aral\u0131\u011f\u0131<\/li>\n<\/ul>\n<p>Hisse senedi, Haziran 2025&#8217;te a\u015f\u0131r\u0131 sat\u0131m ko\u015fullar\u0131na ula\u015ft\u0131ktan sonra klasik toparlanma modelleri sergiliyor. Rs. 81,01 dip seviyesinden son s\u0131\u00e7rama, bu seviyelerde g\u00fc\u00e7l\u00fc kurumsal destek oldu\u011funu g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut temel veriler ve sekt\u00f6r b\u00fcy\u00fcme projeksiyonlar\u0131na dayanarak, i\u015fte ger\u00e7ek\u00e7i fiyat tahminimiz:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: Rs. 125-140 \u2192 <strong>AL<\/strong> tavsiyesi<br \/>K\u00fcresel API talebinin artmas\u0131yla g\u00fc\u00e7l\u00fc toparlanma bekleniyor<\/li>\n<li><strong>2026 Tahmini<\/strong>: Rs. 150-170<br \/>Hindistan&#8217;\u0131n API \u00fcretim geni\u015flemesinden faydalanma<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: Rs. 250-300<br \/>Pazar liderli\u011fi konsolidasyonu ve ihracat b\u00fcy\u00fcmesi<\/li>\n<li><strong>2030 Hedefi<\/strong>: Rs. 400-500<br \/>K\u00fcresel ila\u00e7 tedarik zinciri hakimiyeti<\/li>\n<\/ul>\n<p>Bu projeksiyonlar, Hindistan&#8217;\u0131n API end\u00fcstrisinin %13,7 CAGR b\u00fcy\u00fcme oran\u0131 ve \u015firketin bor\u00e7suz bilan\u00e7o durumu ile uyumludur (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">OMR Global End\u00fcstri Raporu<\/a>).<\/p>\n<h2>\u26a0\ufe0f PAR Yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Risk De\u011ferlendirmesi<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Ana Riskler:<\/h3>\n<ul>\n<li><strong>Y\u00fcksek Volatilite<\/strong>: 52 haftal\u0131k aral\u0131k a\u015f\u0131r\u0131 fiyat dalgalanmalar\u0131n\u0131 g\u00f6steriyor (Rs. 81-348)<\/li>\n<li><strong>Reg\u00fclasyon Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: \u0130la\u00e7 sekt\u00f6r\u00fc s\u00fcrekli d\u00fczenleyici de\u011fi\u015fikliklerle kar\u015f\u0131 kar\u015f\u0131ya<\/li>\n<li><strong>\u0130hracat Hassasiyeti<\/strong>: Gelirin %40&#8217;\u0131 ihracattan, d\u00f6viz dalgalanmalar\u0131na kar\u015f\u0131 hassas<\/li>\n<li><strong>Rekabet Bask\u0131s\u0131<\/strong>: Daha b\u00fcy\u00fck oyuncular API \u00fcretim alan\u0131nda hakim<\/li>\n<li><strong>Hammadde Maliyetleri<\/strong>: Kimyasal girdi fiyatlar\u0131ndaki dalgalanmalar marjlar\u0131 etkiliyor<\/li>\n<\/ul>\n<h3>2025 i\u00e7in Olumlu Sinyaller:<\/h3>\n<ul>\n<li><strong>Bor\u00e7suz \u015eirket<\/strong>: S\u0131f\u0131r bor\u00e7 finansal esneklik sa\u011fl\u0131yor (<a href=\"https:\/\/simplywall.st\/stocks\/in\/pharmaceuticals-biotech\/nse-par\/par-drugs-and-chemicals-shares\">Simply Wall St Analizi<\/a>)<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Hindistan k\u00fcresel API merkezi haline geliyor ve %8 pazar pay\u0131na sahip<\/li>\n<li><strong>Maliyet Avantajlar\u0131<\/strong>: Bat\u0131l\u0131 rakiplere g\u00f6re %40 daha d\u00fc\u015f\u00fck \u00fcretim maliyetleri<\/li>\n<li><strong>Jeopolitik Faydalar<\/strong>: \u00c7in ticaret gerilimleri Hindistanl\u0131 \u00fcreticilere avantaj sa\u011fl\u0131yor<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc Marjlar<\/strong>: %59,80 br\u00fct marj fiyatlama g\u00fcc\u00fcn\u00fc g\u00f6steriyor<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 \u00d6nemli Haber Analizi (Son 6 Ay)<\/h2>\n<h3>Mali Performans G\u00fcncellemeleri:<\/h3>\n<p>\u015eirket, 2026 1. \u00e7eyrek sonu\u00e7lar\u0131nda hisse ba\u015f\u0131na Rs. 2,70 EPS bildirerek y\u0131ll\u0131k Rs. 2,06&#8217;ya k\u0131yasla %31 sa\u011fl\u0131kl\u0131 art\u0131\u015f g\u00f6sterdi (<a href=\"https:\/\/www.valueresearchonline.com\/stocks\/251559\/par-drugs-and-chemicals-ltd\/\">Value Research Online<\/a>). Ancak, Mart 2025 \u00e7eyrek sat\u0131\u015flar\u0131 %2,14 azalarak Rs. 22,33 crore oldu ve baz\u0131 operasyonel zorluklar\u0131 ortaya koydu.<\/p>\n<h3>Operasyonel Verimlilik \u0130yile\u015ftirmeleri:<\/h3>\n<p>\u00d6zellikle, \u015firket Mart 2025 itibar\u0131yla nakit d\u00f6n\u00fc\u015f\u00fcm d\u00f6ng\u00fcs\u00fcn\u00fc sadece 15 g\u00fcne d\u00fc\u015f\u00fcrerek m\u00fckemmel i\u015fletme sermayesi y\u00f6netimi sergiledi (<a href=\"https:\/\/www.screener.in\/company\/PAR\/\">Screener.in Finansallar<\/a>). Bu verimlilik art\u0131\u015f\u0131, sermaye yo\u011fun ila\u00e7 sekt\u00f6r\u00fcnde rekabet avantaj\u0131 sa\u011fl\u0131yor.<\/p>\n<h3>Kurumsal Y\u00f6netim:<\/h3>\n<p>27 Eyl\u00fcl 2025&#8217;te planlanan 26. Ola\u011fan Genel Kurul, istikrarl\u0131 y\u00f6netim ve rutin kurumsal faaliyetleri g\u00f6steriyor, b\u00fcy\u00fck aksakl\u0131klar yok (<a href=\"https:\/\/www.tickertape.in\/stocks\/par-drugs-and-chemicals-PARR\">Tickertape Kurumsal \u0130\u015flemler<\/a>).<\/p>\n<h2>\ud83c\udfaf Yeni Ba\u015flayanlar i\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2>\n<h3>Ciddi Tavsiyeler:<\/h3>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Niyet etti\u011finiz pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fcn %10-20&#8217;si ile ba\u015flayarak suyu test edin<\/li>\n<li><strong>D\u00fc\u015f\u00fc\u015fleri Bekleyin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 Rs. 100 alt\u0131 daha iyi giri\u015f noktalar\u0131 sa\u011flayabilir<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Zamanlama riskini azaltmak i\u00e7in al\u0131mlar\u0131 3-6 ay aras\u0131nda yay\u0131n\u0131z<\/li>\n<\/ol>\n<h3>Esprili Tecr\u00fcbeli Tavsiyesi:<\/h3>\n<p>&#8220;PAR hissesi ticareti, ila\u00e7 \u00fcretimi gibidir &#8211; bazen karl\u0131 form\u00fcl\u00fc g\u00f6rmek i\u00e7in kar\u0131\u015f\u0131m s\u00fcrecine katlanman\u0131z gerekir. Volatilite s\u0131ras\u0131nda panik yapmay\u0131n; bu kimyasallar\u0131n do\u011fru tepki vermesi zaman al\u0131r!&#8221;<\/p>\n<h2>\u2705 Ad\u0131m Ad\u0131m: Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Uluslararas\u0131 Arac\u0131 Kurum Se\u00e7in<\/td>\n<td>NSE\/BSE i\u015flem eri\u015fimini desteklemeli<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>KYC Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Hint piyasas\u0131na eri\u015fim i\u00e7in PAN kart gereklidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>\u0130lk pozisyon i\u00e7in minimum 50$ \u00f6nerilir<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;PAR&#8221; Ticker&#8217;\u0131n\u0131 Aray\u0131n<\/td>\n<td>Ulusal Borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit Emri Verin<\/td>\n<td>Dalgal\u0131 d\u00f6nemlerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu \u0130zleyin<\/td>\n<td>\u0130la\u00e7 hisseleri aktif y\u00f6netim gerektirir<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Stop-Loss Belirleyin<\/td>\n<td>A\u015f\u0131r\u0131 volatiliteye kar\u015f\u0131 koruma sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td>\n<td>Kazan\u00e7 raporlar\u0131 b\u00fcy\u00fck fiyat hareketlerini tetikler<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden \u00dcst\u00fcn<\/h2>\n<p>Pocket Option, PAR yat\u0131r\u0131m\u0131 i\u00e7in m\u00fckemmel \u00f6zelliklerle hisse senedi ticaret eri\u015filebilirli\u011fini devrim niteli\u011finde art\u0131r\u0131yor:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma Avantaj\u0131<\/strong>: Sadece 5$ ile ticarete ba\u015flayarak Par Drugs hisseleriyle stratejileri b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan test etmek i\u00e7in ideal (<a href=\"https:\/\/pocketoption.com\/blog\/en\/interesting\/trading-platforms\/what-is-the-minimum-deposit-in-pocket-option\/\">Pocket Option Para Yat\u0131rma Rehberi<\/a>).<\/li>\n<li><strong>\u015eim\u015fek H\u0131z\u0131nda Do\u011frulama<\/strong>: Tek bir kimlik belgesi ile dakikalar i\u00e7inde KYC tamamlayarak f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda piyasaya haz\u0131r olun.<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla para \u00e7ekme y\u00f6ntemi ile ba\u015far\u0131l\u0131 PAR i\u015flemlerinden kazan\u00e7lar\u0131n\u0131z\u0131 kolayca eri\u015febilirsiniz.<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve profesyonel grafik ara\u00e7lar\u0131, Par Drugs&#8217;\u0131n teknik desenlerini yeni ba\u015flayanlar i\u00e7in bile analiz etmeyi kolayla\u015ft\u0131r\u0131r.<\/p>\n<h2>\ud83c\udfed \u015eirket Genel Bak\u0131\u015f\u0131: Par Drugs 2025<\/h2>\n<p>Par Drugs and Chemicals Limited, 1999&#8217;dan beri faaliyet g\u00f6steren ve Gujarat&#8217;\u0131n Bhavnagar ve Ankleshwar b\u00f6lgelerinde \u00fcretim tesisleri bulunan Hindistan&#8217;\u0131n ila\u00e7 bile\u015fenleri sekt\u00f6r\u00fcnde k\u00f6kl\u00fc bir oyuncudur. \u015eirket, hem yerel hem de uluslararas\u0131 pazarlara hizmet veren 15 aktif farmas\u00f6tik bile\u015fen (API) ve 10 ince kimyasal \u00fcretiminde uzmanla\u015fm\u0131\u015ft\u0131r (<a href=\"https:\/\/www.moneycontrol.com\/india\/stockpricequote\/chemicals\/pardrugschemicals\/PDC02\">Moneycontrol \u015eirket Profili<\/a>).<\/p>\n<h3>G\u00fcncel Pazar Konumu:<\/h3>\n<ul>\n<li>Piyasa De\u011feri: Rs. 133,68 crore<\/li>\n<li>F\/K Oran\u0131: 9,87 (sekt\u00f6re g\u00f6re d\u00fc\u015f\u00fck de\u011ferli)<\/li>\n<li>F\/\u00d6 Oran\u0131: 1,41 (makul de\u011ferleme)<\/li>\n<li>Bor\u00e7: S\u0131f\u0131r bor\u00e7 &#8211; finansal olarak istikrarl\u0131<\/li>\n<\/ul>\n<h3>\u00dcr\u00fcn Portf\u00f6y\u00fc \u015eunlar\u0131 \u0130\u00e7erir:<\/h3>\n<ul>\n<li>Magnezyum hidroksit ve oksit \u00fcr\u00fcnleri<\/li>\n<li>Sucralfate ve almagate BP<\/li>\n<li>\u00c7e\u015fitli magnezyum bile\u015fikleri<\/li>\n<li>Farmas\u00f6tik s\u0131n\u0131f kimyasallar<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/h3>\n<p>Par Drugs, Hindistan&#8217;\u0131n D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc&#8217;n\u00fcn \u00f6n yeterlilik listesine %57 API tedarik etti\u011fi bir sekt\u00f6rde faaliyet g\u00f6stermektedir; bu da PAR gibi \u015firketleri k\u00fcresel sa\u011fl\u0131k tedarik zincirlerinde kritik oyuncular haline getirmektedir (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">K\u00fcresel API Pazar Raporu<\/a>). Bu durum, g\u00fcvenilir farmas\u00f6tik bile\u015fenlere artan k\u00fcresel talep i\u00e7in onlar\u0131 m\u00fckemmel bir konuma getiriyor.<\/p>\n"},"faq":[{"question":"Par Drugs and Chemicals Limited hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Uluslararas\u0131 bir arac\u0131 kurum se\u00e7in, KYC do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"PAR\" sembol\u00fcn\u00fc aray\u0131n, limit emri verin ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"Par Drugs hisselerinin riskleri nelerdir?","answer":"Y\u00fcksek volatilite, d\u00fczenleyici de\u011fi\u015fiklikler, ihracat gelirlerinin d\u00f6viz dalgalanmalar\u0131na duyarl\u0131l\u0131\u011f\u0131, rekabet bask\u0131s\u0131 ve hammadde maliyetlerindeki dalgalanmalar ba\u015fl\u0131ca risklerdir."},{"question":"Par Drugs hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda Rs. 125-140 aral\u0131\u011f\u0131nda al\u0131m \u00f6nerisi, 2026'da Rs. 150-170, 2028'de Rs. 250-300 ve 2030'da Rs. 400-500 hedeflenmektedir."},{"question":"Pocket Option Par Drugs hisseleri i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in ideal bir platformdur."},{"question":"Par Drugs'\u0131n \u00fcr\u00fcn portf\u00f6y\u00fcnde neler var?","answer":"Magnezyum hidroksit ve oksit \u00fcr\u00fcnleri, sucralfate, almagate BP, \u00e7e\u015fitli magnezyum bile\u015fikleri ve farmas\u00f6tik s\u0131n\u0131f kimyasallar bulunmaktad\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Par Drugs and Chemicals Limited hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Uluslararas\u0131 bir arac\u0131 kurum se\u00e7in, KYC do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"PAR\" sembol\u00fcn\u00fc aray\u0131n, limit emri verin ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"Par Drugs hisselerinin riskleri nelerdir?","answer":"Y\u00fcksek volatilite, d\u00fczenleyici de\u011fi\u015fiklikler, ihracat gelirlerinin d\u00f6viz dalgalanmalar\u0131na duyarl\u0131l\u0131\u011f\u0131, rekabet bask\u0131s\u0131 ve hammadde maliyetlerindeki dalgalanmalar ba\u015fl\u0131ca risklerdir."},{"question":"Par Drugs hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda Rs. 125-140 aral\u0131\u011f\u0131nda al\u0131m \u00f6nerisi, 2026'da Rs. 150-170, 2028'de Rs. 250-300 ve 2030'da Rs. 400-500 hedeflenmektedir."},{"question":"Pocket Option Par Drugs hisseleri i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in ideal bir platformdur."},{"question":"Par Drugs'\u0131n \u00fcr\u00fcn portf\u00f6y\u00fcnde neler var?","answer":"Magnezyum hidroksit ve oksit \u00fcr\u00fcnleri, sucralfate, almagate BP, \u00e7e\u015fitli magnezyum bile\u015fikleri ve farmas\u00f6tik s\u0131n\u0131f kimyasallar bulunmaktad\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T09:40:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-13T07:30:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T09:40:50+00:00\",\"dateModified\":\"2025-09-13T07:30:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\"},\"wordCount\":25,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\",\"name\":\"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-28T09:40:50+00:00\",\"dateModified\":\"2025-09-13T07:30:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","og_locale":"tr_TR","og_type":"article","og_title":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T09:40:50+00:00","article_modified_time":"2025-09-13T07:30:15+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","type":"image\/webp"}],"author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T09:40:50+00:00","dateModified":"2025-09-13T07:30:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"wordCount":25,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","name":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-28T09:40:50+00:00","dateModified":"2025-09-13T07:30:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":353861,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Par Drugs and Chemicals Limited (PAR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"pt_AA":{"locale":"pt_AA","id":353864,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"Como comprar a\u00e7\u00f5es da Par Drugs and Chemicals Limited (PAR) - Investimento em a\u00e7\u00f5es da Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/353863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=353863"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/353863\/revisions"}],"predecessor-version":[{"id":373792,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/353863\/revisions\/373792"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=353863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=353863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=353863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}